Prescription drug · ANDA
Ursodiol NDC 55154-2633
Ursodiol 250 mg/1 · Tablet, Film coated · Oral · Cardinal Health 107, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55154-2633-0 | 5515426330055154263300 | 10 BLISTER PACK in 1 BAG (55154-2633-0) / 1 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Oct 31, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ursodiol
- Generic name (nonproprietary)
- ursodiol
- Active ingredients
- Ursodiol — 250 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Cardinal Health 107, LLCNDC labeler code 55154
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202540
- Marketing start
- Listing expires
- Other FDA classes
- Bile Acids and Salts (Chemical structure)
- Identifiers
- Product ID 55154-2633_cc868448-2155-45e6-a13b-72bc0d0f0fc8SPL ID cc868448-2155-45e6-a13b-72bc0d0f0fc8SPL set ID 61dcaec8-3acb-4ef0-afde-65a66e99afa7RxCUI 858751UNII 724L30Y2QR
- Pharmacologic class
- Bile Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N455154263300followed by a unit qualifier and the quantityPackage 55154-2633-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Ursodiol tablets are indicated for the treatment of patients with primary biliary cholangitis (PBC). Ursodiol tablets are bile acids indicated for the treatment of patients with primary biliary cholangitis. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 55154-2633
- What is NDC 55154-2633?
- 55154-2633 is the product NDC for Ursodiol, Ursodiol 250 mg/1 tablet, film coated, listed with the FDA by Cardinal Health 107, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ursodiol.
- What is the active ingredient?
- Ursodiol.
- Who is the labeler?
- Cardinal Health 107, LLC, NDC labeler code 55154. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ursodiol?
- 43 other product NDCs are listed under this name. See all Ursodiol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ursodiol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvPAK | 50268-864 | 50268-0864-13 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | NorthStar Rx LLC | 72603-613 | 72603-0613-01 |
| Ursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | AvKARE | 42291-931 | 42291-0931-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvKARE | 42291-923 | 42291-0923-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-2619 | 72162-2619-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Aurobindo Pharma Limited | 59651-421 | 59651-0421-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | PuraCap Laboratories, LLC | 24658-999 | 24658-0999-10 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Strides Pharma Science Limited | 64380-844 | 64380-0844-0464380-0844-0664380-0844-07 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Laurus Labs Limited | 42385-946 | 42385-0946-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvPAK | 50268-797 | 50268-0797-15 |
Other NDCs under ANDA 202540
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ursodiol | Ursodiol 250 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-6890 |
| Ursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | AvKARE | 42291-931 |
| Ursodiol | Ursodiol 250 mg/1 | Tablet, Film coatedOral | Par Health USA, LLC | 49884-412 |
| Ursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | Par Health USA, LLC | 49884-413 |
| Ursodiol | Ursodiol 250 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-2286 |
| Ursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-2287 |
| Ursodiol | Ursodiol 250 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1500 |
| Ursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1501 |